SBRT may be effective, safe alternative for patients, medically inoperable early-stage lung cancer 07/05/2018 Health Problems
First study of neoadjuvant use of PARP inhibitor shows promise for early-stage, BRCA+ breast cancer patients 06/04/2018 Health Problems
